pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
BIIB-142
Lupus Nephritis
$BIIB
BIOGEN INC.
Phase 2
BIO-106
Solid Tumor
BiOneCure Therapeutics Inc
Preclinical
BIOS: GM I
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)
Sylamore Bio
Preclinical
← prev
page 63 of 231
next →
131
Pain
89
Neurology
1
BIOS:MPS I
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Sylamore Bio
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
no indication
LABS JUVISE
Phase 1
BJ-001
Solid Tumor
BJ Bioscience Inc
Phase 1
BJ-005
Solid Tumor
BJ Bioscience Inc
Phase 2
BLB-101
Coronavirus Disease 2019 (COVID-19)
Blue Lake Biotechnology Inc
Phase 2
BLB-201
Respiratory Syncytial Virus (RSV) Infections
Blue Lake Biotechnology Inc
Phase 1
BLM-11D1
Refractory Acute Myeloid Leukemia
Sichuan Biokin Pharmaceutical Co Ltd
Phase 1
BLM-14D1
Gastrointestinal Tumor
Sichuan Biokin Pharmaceutical Co Ltd
Phase 1
BLM-17D1
Endometrial Cancer
Sichuan Biokin Pharmaceutical Co Ltd
Phase 2
BLU-808
Chronic Inducible Urticaria
Blueprint Medicines Corp
BLUDIGO
BLUDIGO (INDIGOTINDISULFONATE SODIUM)
no indication
PROVEPHARM SAS
Preclinical
BMD-001
Alzheimer's Disease
Biorchestra Co Ltd
Phase 1
BMF-650
Obesity
$BMEA
Biomea Fusion, Inc.
Phase 2
BMND-08
Alzheimer's Disease
Biomind Labs Inc
Phase 1
BMS-986416
Diffuse Cutaneous Systemic Sclerosis
Bristol-Myers Squibb Co
Phase 2
BMS-986446
Alzheimer's Disease
Bristol-Myers Squibb Co
Phase 1
BMS-986497
Myelodysplastic Syndrome (Preleukemia)
Bristol-Myers Squibb Co
Phase 2
BMX-001
High-Grade Glioma
Biomimetix JV LLC
Phase 2
BNT-111
Metastatic Melanoma
$BNTX
BioNTech SE
Phase 3
BNT-113
Recurrent Head And Neck Squamous Cell Carcinoma
$BNTX
BioNTech SE
Phase 2
BOLD-100
Colorectal Cancer
Bold Therapeutics Inc
Phase 2
BOXR-1030
Merkel Cell Carcinoma
SOTIO Biotech AS
Phase 1
BP-1002
Refractory Acute Myeloid Leukemia
$BPTH
BIO-PATH HOLDINGS, INC.
Preclinical
BP-1003
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$BPTH
BIO-PATH HOLDINGS, INC.
Preclinical
BP-2202
Multiple Myeloma (Kahler Disease)
BrightPath Biotherapeutics Co Ltd
Preclinical
BPA
Glioblastoma Multiforme (GBM)
TAE Life Sciences LLC
Preclinical
BPC-157
Inflammation
PharmaTher Holdings Ltd
